Approval · Notice of Compliance 1419 · 2000
PANTOLOC: Notice of Compliance 1419
Issued March 10, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1419
- Date
- March 10, 2000
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 20mg new indication: maintenance treatment of patients with reflux esophagitis
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PANTOLOC | Not yet assigned | — |
| PANTOLOC | 02241804 | Marketed |
Medicinal ingredients
- PANTOPRAZOLE SODIUM 40 MG per TAB
- PANTOPRAZOLE SODIUM 20 MG per TAB